| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |